Eliminate Data Silos With One Digital Unified Platform.
ā¹ Orchestrate + Automate Processes. Unify Data.
ā¹ Cut Lead-Times. Reduce Operational Costs.
ā¹ Accelerate Science with AI-Ready Data.
FROST & SULLIVAN NAMES L7 GLOBAL LEADER IN INNOVATION
L7 achieves the highest innovation Score in 2025 Frost & Sullivan Frost Radarā¢ for Pharmaceutical and Biotech LIMS.
data silos are costing you more than you think
Data silos arenāt just slowing you down; theyāre silently draining your time, your budget, and your competitive edge.
Most life sciences organizations are built on fragmented systems, each with its own language, logic, and limits. The result? Disconnected workflows, unstructured data, and innovation stuck in first gear.
AI won’t help you, unless you fix your data first
Everyoneās racing to implement AI, but without the right data foundation, most efforts fall flat. At the same time, drug development is taking longer and costing more than ever before. Disconnected systems, fragmented workflows, and inaccessible data are delaying therapies, driving up costs, and keeping companies from reaching AI’s full potential.
10 years
According to McKinsey, that’s how long it takes, on average, to deliver new treatments, with inefficiencies dragging out every phase.
$2.3B+
Deloitte states that the cost of bringing a new drug to market is soaring, putting strain on R&D and manufacturing.
<25% AI-readiness
A 2025 McKinsey report indicates that most companies arenāt yet in a position to leverage AI at scale.
unify, contextualize, orchestrate: L7|ESP powers AI-driven science
AI is only as powerful as the data behind it. But in life sciences, silos, inconsistent ontologies, and fragmented systems create an AI chasm, blocking the path to real value. Thatās where L7|ESP comes in. Our composable platform contextualizes data at the source, automates end-to-end processes, and standardizes workflows across research, development, and manufacturing, eliminating silos and laying the groundwork for real AI readiness.
L7|ESP isnāt just a platform; itās your digital backbone. With modular components like L7|MASTER, L7|HUB, L7|ESP CORE, and L7|INTELLIGENCE, it powers AI-ready data, seamless orchestration, and cross-functional collaboration at every stage of your digital journey.
And the best part? L7|ESP layers over your existing systems; no disruptive rip-and-replace required.
L7 IS A DELOITTE FAST 500 COMPANY
We’ve been listed in the Deloitte Fast 500 annual ranking of fastest-growing companies for the 4th consecutive year. What an honor!
why digital-first life sciences teams trust L7|ESP
Digital Unified Platform
L7|ESP connects and orchestrates lab and manufacturing workflows, eliminating silos and ensuring AI-ready data at the source.
- Seamless integration: Works with instruments, equipment, and legacy systems.
- Data contextualization: Captures data at the point of generation, eliminating complex downstream transformations.
- Reduced IT overhead: Minimizes manual intervention and simplifies data management.
- Real-time insights: Transforms raw data into actionable intelligence without degradation over time.
- Adaptable in any IT landscape: Supports both legacy-heavy (brownfield) and newly established (greenfield) environments.
- More than a data lake: A fully
digital unified platform with built-in LIMS, ELN, MES, Scheduling apps , and more.
Compliance + AI-Ready
L7|ESP is GLP, GCP, and GMP-ready, ensuring data integrity, traceability, and AI readiness by structuring information at the point of execution.
- Complete audit trail: Captures instruments, reagents, media, and personnel for every experiment or process.
- Automatic data contextualization: Eliminates the need for complex ETL pipelines and siloed storage.
- AI-ready foundation: Organizes data for seamless AI/ML training, including LLMs.
- Enhanced regulatory compliance: Simplifies audits, submissions, and root cause analysis.
- Single source of truth: Ensures structured, intact, and contextualized data for improved decision-making.
Rapid Tech Transfers
L7|ESP streamlines internal and external tech transfers, accelerating time-to-market for drug products, biologics, and diagnostics.
- Seamless digital transfers: Eliminates process variations and the need to revert to paper.
- Unified data + processes: Ensures consistency across research, development, clinical trials, and commercialization.
- gxP-compliant: Maintains data integrity and harmonization throughout the product lifecycle.
- CRO/CDMO-ready: Enables smooth collaboration with external partners.
- Faster scale-up + commercialization: Reduces delays and inefficiencies in tech transfer.
Portfolio Optimization
L7|ESP simplifies IT ecosystems, reducing costs and freeing resources for innovation.
- Eliminates redundancies: Orchestrates interactions across legacy systems, instruments, and equipment.
- Reduces IT complexity: Streamlines architecture to optimize resource allocation.
- Future-proof framework: Supports both monolithic and next-gen solutions.
- Phased system transitions: Enables seamless onboarding and retirement of technologies.
- Unlocks AI + ML potential: Frees budgets for transformative technologies like Gen
AI , machine learning, and Agentic AI.
Operational Excellence
L7|ESP unifies research, lab, and manufacturing operations, eliminating inefficiencies and enhancing visibility
- End-to-end integration: Connects ELN, LIMS, MES, and Scheduling in a single platform.
- Optimized workflows: Replaces paper-based processes to improve efficiency.
- Material + capacity management: Ensures better resource utilization.
- Real-time operational insights: Provides answers to critical questions on test timelines, batch delays, and resource allocation.
- Smarter decision-making: Enhances visibility across Research, Development, and Manufacturing.
blog posts
Building the Digital Backbone for Scalable Cell Therapies: Key Insights...
Every Technology Wave Needs Its Infrastructure: Why AI in Life...
The Best Way to Achieve AI-Readiness for Life Sciences
The Ontology Advantage: Enabling Smarter, Connected Decisions in Life Sciences...
meet us at
latest news
Leica Biosystems and L7 Informatics Announce Strategic Partnership to Develop...
Frost & Sullivan TGL | Reimagining LIMS: How L7 Informatics...
L7 Informatics is Unifying Life Sciences: Breaking Down Data Silos...
L7 Informatics Named Top Innovator in 2025 Frost & Sullivan...
recent case studies
Case Study: Building a Digital Foundation for Scientific Innovation with...
Case Study: Advancing DNA Sequencing Services in a Public Sector...
Case Study: Modernizing Agricultural Trait Development with a Configurable Digital...
Case Study: Supporting Cellipont Bioservices in Their Mission to Advance...
FAQ: L7 in 7 questions
What does L7 Informatics do?
L7 Informatics provides a digital unified platform (L7|ESP) that eliminates data silos in pharmaceutical, biotech, CDMO, diagnostics, and research organizations. Unlike traditional point solutions that fragment data across separate LIMS, ELN, MES, and scheduling systems, L7|ESP contextualizes data at the source and orchestrates workflows across research, development, and manufacturing, creating an AI-ready data foundation.
What is the main problem L7 solves?
Life sciences organizations struggle with data silos caused by disconnected systems, each with its own language, logic, and limits. This fragmentation delays drug development, increases costs, blocks AI implementation, and makes it impossible to get a unified view across research, development, and manufacturing. L7|ESP solves this by providing a single unified platform that contextualizes data at the point of capture and orchestrates end-to-end workflows.
Who are L7’s customers?
L7 serves pharmaceutical companies, biotech organizations, CDMOs (contract development and manufacturing organizations), diagnostics companies, cancer centers, academic research institutions, CROs, ag-bio companies, and life science tool manufacturers. Customers range from emerging biotech startups to Fortune 500 pharmaceutical companies, including QIAGEN, Dana-Farber Cancer Institute, The Jackson Laboratory, Cellipont Bioservices, and Quest Diagnostics.
How is L7 different from traditional LIMS or ELN vendors?
Traditional LIMS and ELN systems are point solutions that create data silos and require complex integration to work together. L7|ESP is a unified platform that replaces separate LIMS, ELN, MES, and scheduling systems with a single integrated solution. L7|ESP contextualizes data at the source using ontology-driven knowledge graphs, making data AI-ready without requiring extensive ETL pipelines or data transformation. Additionally, L7|ESP layers over existing infrastructure without requiring rip-and-replace.
Has L7 received industry recognition?
Yes. Frost & Sullivan named L7 Informatics the Global Leader in Innovation in its 2025 Frost Radarā¢ for Pharmaceutical and Biotech LIMS, with the highest innovation score among all evaluated vendors. L7 has also been recognized in the Deloitte Technology Fast 500 for four consecutive years (2021-2024) as one of North America’s fastest-growing technology companies, and has been identified in 30+ Gartner Hype Cycles and Market Guides.
What is AI-readiness and why does it matter?
AI-readiness means having data that is structured, contextualized, and accessible in a way that AI and machine learning systems can use effectively. According to Gartner research, while 85% of life sciences organizations are pursuing AI initiatives, fewer than 25% have the unified data infrastructure necessary to deploy AI at scale. L7|ESP creates AI-ready data by contextualizing information at the point of execution using knowledge graphs, eliminating the need for complex data transformation pipelines.
Does L7 work with existing systems?
Yes. L7|ESP is designed to layer over existing IT infrastructure and integrate with instruments, equipment, legacy systems, and other enterprise applications. This means organizations can adopt L7|ESP without requiring a disruptive rip-and-replace of their current systems, enabling phased digital transformation.
